Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases

Abstract Prion diseases are a group of fatal neurodegenerative disorders characterized by the abnormal folding of cellular prion proteins into pathogenic forms. The development of these diseases is intricately linked to oxidative stress and mitochondrial dysfunction. Irisin, an endogenous myokine, h...

Full description

Saved in:
Bibliographic Details
Main Authors: Pei Wen, Zhixin Sun, Dongming Yang, Jie Li, Zhiping Li, Mengyang Zhao, DongDong Wang, Fengting Gou, Jingjing Wang, Yuexin Dai, Deming Zhao, Lifeng Yang
Format: Article
Language:English
Published: Nature Publishing Group 2025-02-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-025-07390-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861548089606144
author Pei Wen
Zhixin Sun
Dongming Yang
Jie Li
Zhiping Li
Mengyang Zhao
DongDong Wang
Fengting Gou
Jingjing Wang
Yuexin Dai
Deming Zhao
Lifeng Yang
author_facet Pei Wen
Zhixin Sun
Dongming Yang
Jie Li
Zhiping Li
Mengyang Zhao
DongDong Wang
Fengting Gou
Jingjing Wang
Yuexin Dai
Deming Zhao
Lifeng Yang
author_sort Pei Wen
collection DOAJ
description Abstract Prion diseases are a group of fatal neurodegenerative disorders characterized by the abnormal folding of cellular prion proteins into pathogenic forms. The development of these diseases is intricately linked to oxidative stress and mitochondrial dysfunction. Irisin, an endogenous myokine, has demonstrated considerable neuroprotective potential due to its antioxidative properties. However, the protective effects of irisin against prion diseases have yet to be clarified. Our findings indicate that treatment with exogenous irisin can mitigate the apoptosis induced by PrP106–126. Additionally, irisin significantly reduces oxidative stress and alleviates the mitochondrial dysfunction triggered by PrP106–126. Furthermore, irisin treatment targets uncoupling protein 2 (UCP2) and activates the AMPK-Nrf2 pathway, substantially improving oxidative stress and mitochondrial dysfunction in N2a cells induced by PrP106–126. These results suggest that irisin represents a novel and promising therapeutic approach for treating prion diseases.
format Article
id doaj-art-4274e79fdc7241cdbe54ce784d96df2b
institution Kabale University
issn 2041-4889
language English
publishDate 2025-02-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-4274e79fdc7241cdbe54ce784d96df2b2025-02-09T12:56:42ZengNature Publishing GroupCell Death and Disease2041-48892025-02-0116111410.1038/s41419-025-07390-wIrisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseasesPei Wen0Zhixin Sun1Dongming Yang2Jie Li3Zhiping Li4Mengyang Zhao5DongDong Wang6Fengting Gou7Jingjing Wang8Yuexin Dai9Deming Zhao10Lifeng Yang11National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityNational Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural UniversityAbstract Prion diseases are a group of fatal neurodegenerative disorders characterized by the abnormal folding of cellular prion proteins into pathogenic forms. The development of these diseases is intricately linked to oxidative stress and mitochondrial dysfunction. Irisin, an endogenous myokine, has demonstrated considerable neuroprotective potential due to its antioxidative properties. However, the protective effects of irisin against prion diseases have yet to be clarified. Our findings indicate that treatment with exogenous irisin can mitigate the apoptosis induced by PrP106–126. Additionally, irisin significantly reduces oxidative stress and alleviates the mitochondrial dysfunction triggered by PrP106–126. Furthermore, irisin treatment targets uncoupling protein 2 (UCP2) and activates the AMPK-Nrf2 pathway, substantially improving oxidative stress and mitochondrial dysfunction in N2a cells induced by PrP106–126. These results suggest that irisin represents a novel and promising therapeutic approach for treating prion diseases.https://doi.org/10.1038/s41419-025-07390-w
spellingShingle Pei Wen
Zhixin Sun
Dongming Yang
Jie Li
Zhiping Li
Mengyang Zhao
DongDong Wang
Fengting Gou
Jingjing Wang
Yuexin Dai
Deming Zhao
Lifeng Yang
Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases
Cell Death and Disease
title Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases
title_full Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases
title_fullStr Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases
title_full_unstemmed Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases
title_short Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases
title_sort irisin regulates oxidative stress and mitochondrial dysfunction through the ucp2 ampk pathway in prion diseases
url https://doi.org/10.1038/s41419-025-07390-w
work_keys_str_mv AT peiwen irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT zhixinsun irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT dongmingyang irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT jieli irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT zhipingli irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT mengyangzhao irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT dongdongwang irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT fengtinggou irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT jingjingwang irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT yuexindai irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT demingzhao irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases
AT lifengyang irisinregulatesoxidativestressandmitochondrialdysfunctionthroughtheucp2ampkpathwayinpriondiseases